Want to see HK:2219 full AI Analyst Report?
2219 Stock Chart & Stats
HK$2.71
HK$0.04(1.51%)
At close: 4:00 PM EST
HK$2.71
HK$0.04(1.51%)
Day’s Range― - ―
52-Week RangeHK$2.20 - HK$3.14
Previous CloseN/A
Volume266.00K
Average Volume (3M)722.53K
Market Cap
HK$1.75B
Enterprise ValueHK$1.23B
Total Cash (Recent Filing)HK$1.49B
Total Debt (Recent Filing)HK$237.74M
Price to Earnings (P/E)8.1
Beta0.73
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.29%
Share Statistics
EPS (TTM)0.26
Shares Outstanding705,180,500
10 Day Avg. Volume521,468
30 Day Avg. Volume722,533
Financial Highlights & Ratios
PEG Ratio-1.33
Price to Book (P/B)0.72
Price to Sales (P/S)1.28
P/FCF Ratio15.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.25
Revenue Forecast (FY)HK$1.47B
Bulls Say, Bears Say
Bulls Say
Sustained ProfitabilityHealthy 2025 gross, EBIT and net margins indicate the business generates robust operating profits and structural pricing power. Durable margins support reinvestment, dividend capacity and resilience to cyclical patient-volume swings over the next 2–6 months.
Conservative Balance SheetVery low leverage and a large equity base provide financial flexibility for capital spending, acquisitions, or buffer against demand volatility. This conservative capital structure reduces refinancing risk and supports durable operational continuity.
Diversified Healthcare Revenue StreamsA dual model of clinical ophthalmic services plus retail optical product sales creates multiple, complementary revenue streams and cross-sell opportunities. This mix stabilizes cash generation and patient lifetime value versus a single-product provider.
Bears Say
Top-line ContractionA decline in revenue in 2025 signals weakening demand or competitive pressure that can persist beyond a quarter. Sustained top-line contraction reduces room to expand margins and limits reinvestment capacity, pressuring medium-term growth prospects.
Weakened Cash GenerationA sharp drop in free cash flow and OCF below net income point to deteriorating cash conversion, likely from higher capex or working-capital needs. This reduces available funds for dividends, buybacks, or strategic investments and raises execution risk.
Declining Return ProfileFalling returns on equity indicate the company is generating lower profits per unit of shareholder capital. Over the medium term this may reflect competitive erosion or inefficient capital allocation, pressuring shareholder returns and valuation drivers.
Chaoju Eye Care Holdings Ltd. News
2219 FAQ
What was Chaoju Eye Care Holdings Ltd.’s price range in the past 12 months?
Chaoju Eye Care Holdings Ltd. lowest stock price was HK$2.20 and its highest was HK$3.14 in the past 12 months.
What is Chaoju Eye Care Holdings Ltd.’s market cap?
Chaoju Eye Care Holdings Ltd.’s market cap is HK$1.75B.
When is Chaoju Eye Care Holdings Ltd.’s upcoming earnings report date?
Chaoju Eye Care Holdings Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 61 days.
How were Chaoju Eye Care Holdings Ltd.’s earnings last quarter?
Chaoju Eye Care Holdings Ltd. released its earnings results on Mar 31, 2026. The company reported HK$0.11 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.11.
Is Chaoju Eye Care Holdings Ltd. overvalued?
According to Wall Street analysts Chaoju Eye Care Holdings Ltd.’s price is currently Overvalued.
Does Chaoju Eye Care Holdings Ltd. pay dividends?
Chaoju Eye Care Holdings Ltd. pays a Semiannually dividend of HK$0.242 which represents an annual dividend yield of 9.29%. See more information on Chaoju Eye Care Holdings Ltd. dividends here
What is Chaoju Eye Care Holdings Ltd.’s EPS estimate?
Chaoju Eye Care Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chaoju Eye Care Holdings Ltd. have?
Chaoju Eye Care Holdings Ltd. has 705,180,500 shares outstanding.
What happened to Chaoju Eye Care Holdings Ltd.’s price movement after its last earnings report?
Chaoju Eye Care Holdings Ltd. reported an EPS of HK$0.11 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.379%.
Which hedge fund is a major shareholder of Chaoju Eye Care Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2219
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chaoju Eye Care Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.45%
12-Months-Change
Fundamentals
Return on Equity
7.71%
Trailing 12-Months
Asset Growth
9.69%
Trailing 12-Months
Company Description
Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it offers Amblyopia recovery services; and sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―
Options Prices
Currently, No data available
---